✉news BusinessMarkets first seen 6 d ago, last 6 d ago, peak #27
Cencora Still Looks Undervalued After 173% Stock Surge
Original: Cencora (COR) Stock Still Looks Undervalued After Its 173% Run
Cencora shares have climbed roughly 173%, yet analysts argue the drug distribution giant still trades below its intrinsic value. Commentary highlights the company's steady earnings growth and defensive business model as reasons the valuation gap may persist, prompting investors to debate whether there is still room to buy after such a steep run.
Why now: Investors are reassessing whether the pharmaceutical distributor remains a buy after an exceptional share price rally.
Rank over time, top of the chart is #1. 2 snapshots from 6 d ago to 6 d ago.
Evidence
- Cencora (COR) Stock Still Looks Undervalued After Its 173% Run · Yahoo Finance
API: https://socialmediatrends-api.osmike.com/v1/trends/4441989